Osiris Therapeutics (OSIR) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Weighted average common shares (basic) (in shares): 34.44M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Weighted average common shares (basic) (in shares): 34.44M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q3 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $17.2 million versus the consensus estimate of $14.8 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carriage Services (CSV) Misses Q3 EPS by 22c; Offers Guidance
- Arq, Inc. (ARQ) Misses Q3 EPS by 3c ; Offers Guidance
- Liberty Latin America (LILA) Reports Q3 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
